Results 141 to 150 of about 1,097,723 (197)

Modifiable determinants of adherence to tyrosine kinase inhibitors in classical myeloproliferative neoplasms: A mixed-methods systematic review protocol. [PDF]

PLoS One
Inouye FC, Teo V, Clarke J, Georgopoulou S, Freato Gonçalves AMR, de Figueiredo-Pontes LL, Régis Leira Pereira L, Chapman S.   +7 more
europepmc   +1 more source

Peripheral and central nervous system toxicities of Bruton tyrosine kinase Inhibitors: a real-world pharmacovigilance study. [PDF]

Front Med (Lausanne)
Zhang J.
europepmc   +1 more source

LPIN2 contributes to tyrosine kinase inhibitor resistance via activation of PI3K pathway. [PDF]

Transl Lung Cancer Res
Zhou G, Zhao K, Luo H, Ku Y, Peng H, Li S, Zhou W, Luo N, Liu L, Chen Y.   +9 more
europepmc   +1 more source

C-MET tyrosine kinase receptor: mechanisms, clinical applications and future perspectives in cancer therapy. [PDF]

Signal Transduct Target Ther
Zhu C, Li Y, Xu H, Sun L, Wei Y, Ma C, Chen Q, He X.   +7 more
europepmc   +1 more source

Inhibition of AXL receptor tyrosine kinase increases osteoblast function and bone mass. [PDF]

Bone Res
Ahmad M, Kölbl C, Jan I, Dorn AK, Özkan B, Olde Heuvel F, Yilmaz D, Wagner A, Vujic Spasic M, Krüger BT, Lee S, Roselli F, Ignatius A, Tuckermann J.   +13 more
europepmc   +1 more source

Hypomagnesemia in patients on oral EGFR tyrosine kinase inhibitors: renal magnesium wasting or concurrent confounders? [PDF]

Clin Kidney J
Ilyas M, Nguyen J, Shettigar S, Rathi K, Kim E, LeClaire J, Mathavan A, Mathavan A, Fares A, Shah CV.   +9 more
europepmc   +1 more source

Regulation of oestrogen signalling by the receptor tyrosine kinase cKIT stabilises Barrett's oesophagus pre-malignant state. [PDF]

Biol Open
Suen KM, Mohajerani SZ, Tyrer PG, Clark HW, Jones CM, Ladbury JE.   +5 more
europepmc   +1 more source

Tyrosine kinase inhibitor-associated cerebral vasculopathy with a distinct non-enhancing vessel wall phenotype: a case report. [PDF]

BMC Neurol
Yang JE, Jeon JH, Do YR, Yun J.
europepmc   +1 more source

Tyrosine kinase inhibitors and molecularly driven therapeutic approaches for canine lymphoma: a systematic review and meta-analysis. [PDF]

Front Vet Sci
Chen Y, Gao Y, Li S, Liu B, Nolte I, Murua Escobar H, Yu F.   +6 more
europepmc   +1 more source